PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.33%
Revenue growth at 50-75% of ADI's 0.56%. Martin Whitman would worry about competitiveness or product relevance.
-1.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-542.50%
Negative EBIT growth while ADI is at 0.86%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-231.58%
Negative operating income growth while ADI is at 0.86%. Joel Greenblatt would press for urgent turnaround measures.
-293.42%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-274.42%
Negative EPS growth while ADI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-274.42%
Negative diluted EPS growth while ADI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.10%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-2.51%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
2.32%
Dividend growth of 2.32% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-7.27%
Negative OCF growth while ADI is at 300.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-52.53%
Negative FCF growth while ADI is at 80.18%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
53.71%
10Y revenue/share CAGR under 50% of ADI's 165.76%. Michael Burry would suspect a lasting competitive disadvantage.
11.08%
5Y revenue/share CAGR under 50% of ADI's 78.90%. Michael Burry would suspect a significant competitive gap or product weakness.
3.47%
3Y revenue/share CAGR under 50% of ADI's 59.50%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
12095.78%
5Y OCF/share CAGR above 1.5x ADI's 148.51%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-44.04%
Negative 3Y OCF/share CAGR while ADI stands at 141.40%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-937.41%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1.99%
Negative 5Y net income/share CAGR while ADI is 5479.17%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-193.53%
Negative 3Y CAGR while ADI is 225.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
50.55%
5Y equity/share CAGR at 50-75% of ADI's 72.51%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
66.64%
3Y equity/share CAGR at 75-90% of ADI's 74.47%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
108.73%
Dividend/share CAGR of 108.73% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-69.20%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
33.29%
3Y dividend/share CAGR of 33.29% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
10.02%
AR growth well above ADI's 2.30%. Michael Burry fears inflated revenue or higher default risk in the near future.
-13.16%
Inventory is declining while ADI stands at 12.27%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.42%
Asset growth at 50-75% of ADI's 5.01%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-3.93%
We have a declining book value while ADI shows 7.99%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.26%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
90.64%
R&D growth drastically higher vs. ADI's 1.79%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.